Medical massage as a physiotherapeutic method in benign prostatic hyperplasia in men

Journal of Bodywork and Movement Therapies

Volumn 11, Issue 2, 2007, Pages 121-128

  Kassolik, Krzysztof ^a   Andrzejewski, Waldemar ^a   Brzozowski, Marcin ^a   Trzesicka, Ewa ^a   Apoznanski, Wojciech ^b   Szydelko, Tomasz ^b   Steciwko, Andrzej ^b   Staniszewski, Andrzej ^b   Bujnowska Fedak, Maria ^b  

^a UNIVERSITY SCHOOL OF PHYSICAL EDUCATION   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Benign prostatic hyperplasia; Lower urinary tract syndrome; Massage; Miction; Physiotherapy; Prostate

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; HUMAN; LOWER URINARY TRACT SYMPTOM; MALE; MASSAGE; MICTURITION; PHYSIOTHERAPY; PROSTATE; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RATING SCALE;

EID: 33947197798     PISSN: 13608592     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbmt.2006.08.003     Document Type: Article

References (25)

1. Abrams, P., Buzelin, J.M., Griffiths, et al., 1998. The urodynamic assessment of lower urinary tract symptoms. In: Denis, L., Griffiths, K., Khoury, S., Cockett, A.T.K., McConnell, J., Chatelain, C., et al. (Eds.), Procedings-Fourth International Consultation on BPH S.C.I. Paris, pp. 323-378.
2. Barral J.P., and Mercier P. Urogenital Manipulation (1993), Eastland Press, Seatlle, WA
3. Barral J.P., and Mercier P. Visceral Manipulation (2003), Eastland Press, Seatlle, WA
4. Berry S.J., Coffey D.S., Walsh P.C., and Ewing L. The development of human benign prostatic hyperplasia with age. Journal of Urology 132 (1984) 474-479
5. Barry, M.J., Boyl, P., Garraway, M., et al., 1993. Epidemiology and natural history of BPH. In: The Second International Consultation on Benign Prostatic Hyperplasia (BPH) Paris, June 27-30, pp. 19-28.
6. Bosch J.L., Hop W.C., Kirkels W.J., and Schroder F.H. The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age; prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. British Journal of Urology May 75 5 (1995) 622-630
7. Boyle P., Maisonneuve P., and Steg A. Decrease in mortality from benign prostatic hyperplasia: a major unheralded health triumph. Journal of Urology 155 (1996) 176-180
8. Chute C.G., Panser L.A., Girman C.J., et al. The prevalence of prostatism: a population based survey of urinary symptoms. Journal of Urology 150 (1993) 85-89
9. De la Rosette J., Perachino M., Thomas D., et al. Guidelines on benign prostatic hyperplasia. EAU guidelines. European Urology 40 (2001) 256-263
10. Donovan J.L., Kay H.E., Petrs T.J., et al. Using the ICSOoL to measure the impact of lower urinary tract symptoms on quality of life: evidence from the ICS-BPH study. International Continence Society-BPH. British Journal of Urology 80 (1997) 712-721
11. Girman C.J., Jacobsen S.J., Guess H.A., et al. Natural history of prostatism: relation among symptoms, prostate volume and peak urinary flow. Journal of Urology 153 (1995) 1510-1515
12. Goats G.C. Massage-the scientific basis of an ancient art: part 2. Physiological and therapeutic effects. British Journal of Sport Medicine 28 (1994) 153-156
13. Griffiths, K., Akaza, H., Eaton, C.L., et al., 1993. Regulation of prostatic growth. In: The Second International Consultation on Benign Prostatic Hyperplasia (BPH) Paris, June 27-30, pp. 49-75.
14. Hald T. Urodynamics in benign prostatic hyperplasia. A survey. Prostate Suppl 2 (1989) 69-77
15. Hald, T., 2000. Treatment for benign prostatic hyperplasia. Course Book of the Fifth Annual European Course in Urology, Palermo, Italy, September 9-13, pp. 13-30.
16. Hald, T., Brading, A.F., Elbadawi, et al., 1998. Pathophisiology of the urinary bladder in obstruction and ageing. In: Denis, L., Griffiths, K., Khoury, S., Cockett, A.T.K., McConnell, J., Chatelain, C., et al. (Eds.), Procedings-Fourth International Consultation on BPH S.C.I, Paris, pp. 131-178.
17. In: Hamilton W.J. (Ed). Textbook of Human Anatomy (1976), The Macmillan Press Ltd., London and Basingstoke
18. Hansen B.J., et al. Validation of the self-administered Danish prostatic symptom score (DAN-PSS-1) system for use in benign prostatic hyperplasia. British Journal of Urology 76 (1995) 451-458
19. Jarema R., Szostek R., and Otłowski M. Zapalenie gruczołu krokowego. Terapia 2 (1999) 23-24
20. Kassolik K., Krawiecka-Jaworska E., and Andrzejewski W. Próba oceny wspomagaja{ogonek}cego leczenia za pomoca{ogonek} masażu medycznego medycznego łagodnym przeroście stercza. Polska Medycyna Rodzinna 3 (2001) 327-329
21. McConnell, J.D., et al., 1994. Benign prostatic hyperplasia: diagnosis and treatment. Clinic Pract. Guidel. Number 8 AHCTPR Publikation No 94-0582. Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Services. Rockville, MD.
22. Samuel, B., Adkins III, M.D., Figler, R.A., 2000. Hip Pain and Athletes, vol. 61, pp. 2109-2120.
23. Vallancien G. The need for an international classification of benign prostatic hyperplasia. European Urology 33 (1998) 248-250
24. Walsh P.C., Retik A.B., Vaughan E.D., and Wein A.J. Epidemiology, Etiology, Pathophisiology, and Diagnosis of Benign Prostatic Hyperplasia from Campbell's Urology. Seventh ed (1998), W.B Saunders Comp. pp. 1429-1442
25. Walsh P.C., Retik A.B., Vaughan E.D., and Wein A.J. Physiology and Pharmacology of the Bladder and urethra. Campbell's Urology. Seventh ed (1998), W.B Saunders Comp. pp. 870-906